✦ LIBER ✦

Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma

✍ Scribed by Falk, S; Anthoney, A; Eatock, M; Van Cutsem, E; Chick, J; Glen, H; Valle, J W; Drolet, D W; Albert, D; Ferry, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CPT-11 plus cisplatin in patients with a

✍ Jaffer A. Ajani; Jackie Baker; Peter W. T. Pisters; Linus Ho; Paul F. Mansfield; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Phase II study of cetuximab in combinati

✍ Pinto, C; Di Fabio, F; Barone, C; Siena, S; Falcone, A; Cascinu, S; Rojas Llimpe 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 341 KB

A phase II open-label study of DHA-pacli

✍ Robert J. Jones; Robert E. Hawkins; Martin M. Eatock; David R. Ferry; Ferry A. L 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 265 KB

Neoadjuvant Chemotherapy, Surgery, and A

✍ Elliot Newman; Milan Potmesil; Theresa Ryan; Stuart Marcus; Spiros Hiotis; Herma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Phase II study of trastuzumab and cispla

✍ Cristina Grávalos; Carlos Gómez-Martín; Fernando Rivera; Inmaculada Alés; Bernar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 424 KB

Results of docetaxel plus oxaliplatin (D

✍ Richards, Donald; Kocs, Darren M.; Spira, Alexander I.; David McCollum, A.; Diab 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 395 KB